Breaking News Instant updates and real-time market news.

HPE

HP Enterprise

$15.24

0.245 (1.63%)

, SPLK

Splunk

$102.15

0.72 (0.71%)

07:15
07/10/18
07/10
07:15
07/10/18
07:15

Maxim to hold a bus tour

4th Annual Silicon Valley Bus Tour travels throughout Silicon Valley visiting various companies on July 10.

HPE

HP Enterprise

$15.24

0.245 (1.63%)

SPLK

Splunk

$102.15

0.72 (0.71%)

PSTG

Pure Storage

$24.09

-0.325 (-1.33%)

NTAP

NetApp

$79.39

0.61 (0.77%)

CSCO

Cisco

$42.69

-0.03 (-0.07%)

NTNX

Nutanix

$53.13

-0.63 (-1.17%)

  • 10

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

  • 16

    Aug

  • 04

    Sep

  • 10

    Jul

HPE HP Enterprise
$15.24

0.245 (1.63%)

06/28/18
NOMU
06/28/18
INITIATION
Target $160
NOMU
Buy
Nomura initates IBM with Buy, HP Enterprise with Neutral
Nomura Instinet analyst Jeffrey Kvaal initiated coverage of IBM (IBM) with a Buy rating and $160 price target and HP Enterprise (HPE) with a Neutral rating and $16 price target. IBM's push into cloud, security, and artificial intelligence appears to be more thorough than HP Enterprise's shift toward networking and hybrid cloud support, Kvaal tells investors in a research note. The analyst considers IBM's offerings in cloud, analytics and security to be differentiated. He thinks the potential 5% growth in analytics and 20% growth in cloud and security can be durable. IBM's growth is not reflected in current estimates or the multiple, Kvaal contends. On the other hand, he believes HP Enterprise may miss out on the rising percentage of IT spending without a full cloud strategy or a sizeable security story. He sees this as limiting the company's long-term revenue growth prospects.
06/28/18
NOMU
06/28/18
INITIATION
Target $16
NOMU
Neutral
HP Enterprise initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal started HP Enterprise with a Neutral rating and $16 price target.
05/21/18
LOOP
05/21/18
NO CHANGE
Target $23
LOOP
Buy
HP Enterprise has multiple catalysts for next 2-3 years, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $23 price target on HP Enterprise (HPE), saying the company has multiple catalysts for the next 8-12 quarters while generating "incremental earnings" relative to its FY18 guidance. Baruah adds that the company's Tier 1 Cloud computing business with Microsoft (MSFT) is no longer on the decline, while all of its other segments are either flat or growing. The analyst states that these trends are not "well appreciated" by investors, and that the company could "handily" beat on earnings when it reports results tomorrow.
05/23/18
LOOP
05/23/18
NO CHANGE
Target $23
LOOP
Buy
HP Enterprise has multiple catalysts over the next 2-3 years, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $23 price target on HP Enterprise (HPE) after its Q2 earnings, saying he continues to expect the company to approach $2.00 EPS by FY20. The analyst states that HP's Tier 1 cloud business with Microsoft (MSFT) is no longer declining, while all of its other businesses are flat or growing. Baruah also expects the company to pass on about 30c to the bottom line in FY19-FY20 related to the cost savings from its NEXT initiative.
SPLK Splunk
$102.15

0.72 (0.71%)

06/15/18
06/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Southwest (LUV) downgraded to Hold from Buy at Argus with analyst John Staszak saying that despite being well managed and financially strong, its focus on the domestic market will lead to slower relative growth based on better expected performance in the international space. 2. Motorcar Parts (MPAA) downgraded to Neutral from Buy at Roth Capital with analyst Matt Koranda saying he expects margin erosion to intensify in the coming quarters as better industry growth is awaited. 3. BHP Billiton (BHP) and Rio Tinto (RIO) were downgraded to Hold from Buy at Investec. 4. AEGON (AEG) downgraded to Underperform from Neutral at BofA/Merrill with analyst Michael van Wegen citing "relatively strong" stock performance. 5. Splunk (SPLK) downgraded to Sell from Neutral at Citi with analyst Walter Pritchard saying he sees "growth drivers plateauing" and "some warning signs in numbers." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/15/18
SBSH
06/15/18
DOWNGRADE
Target $98
SBSH
Sell
Citi downgrades Splunk to Sell on 'plateauing' growth drivers
Citi analyst Walter Pritchard downgraded Splunk (SPLK) to Sell from Neutral with an unchanged price target of $98. The stock in premarket trading is down 4%, or $4.72, to $114.78. The analyst sees "growth drivers plateauing" and "some warning signs in numbers." Splunk is facing increasing competition, adoption challenges caused by a "persistently unconventional" pricing model and market share in security nearing levels where others have had challenge breaking through, Pritchard tells investors in a research note. Further, he believes the stock is "vulnerable" with a valuation in-line with high-growth software-as-a-service app players. The analyst recommends Salesforce (CRM) and Salesforce (NOW) or security peer Palo Alto Networks (PANW) over Splunk (SPLK).
05/25/18
WELS
05/25/18
NO CHANGE
Target $135
WELS
Outperform
Splunk price target raised to $135 from $120 at Wells Fargo
Wells Fargo analyst Philip Winslow raised his price target for Splunk to $135 saying the company reported solid Q1 results with revenue, operating margins, and earnings above consensus expectations. The analyst continues to believe that Splunk can sustain "robust" revenue and cash flow growth due to its "differentiated, disruptive technology and continued scale in its operating model." He keeps an Outperform rating on the shares.
06/15/18
SBSH
06/15/18
DOWNGRADE
SBSH
Sell
Splunk downgraded to Sell from Neutral at Citi
Citi analyst Walter Pritchard downgraded Splunk to Sell on signs the company's growth is plateauing.
PSTG Pure Storage
$24.09

-0.325 (-1.33%)

05/22/18
SRCH
05/22/18
NO CHANGE
Target $30
SRCH
Buy
Pure Storage price target raised to $30, buy on weakness, says Summit Insights
Summit Insights analyst Srini Nandury raised Buy rated Pure Storage's price target to $30 from $25 following another "solid" quarter. The analyst has increased confidence Pure Storage will continue to post solid growth, driven by Flash Blade traction and continued momentum in Flash Array. Further, Nandury expects disruptions at EMC/Dell will be a benefit to the company, and other placers in the space, and recommends using weakness in Pure Storage shares as a buying opportunity.
05/22/18
BMOC
05/22/18
NO CHANGE
Target $29
BMOC
Outperform
Pure Storage price target raised to $29 from $25 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Pure Storage to $29 after its Q1 results, with revenue and operating margins exceeding the company's prior forecasts. The analyst believes that operating profitability can be expanded further to reach high single digits in FY20 while also noting the near-doubling of Q1 international business. Long keeps his Outperform rating on Pure Storage, adding that the company has the flexibility to pursue M&A following its recent debt offering.
06/05/18
STFL
06/05/18
INITIATION
Target $23
STFL
Hold
Pure Storage resumed with a Hold at Stifel
Stifel analyst Matthew Sheerin resumed coverage of Pure Storage with a Hold rating and $23 price target, stating that he expects significant leverage and cash-flow generation as volumes increase but also noting that the shares are trading at a "fair" valuation that is at the upper end of their historic average.
05/22/18
MAXM
05/22/18
NO CHANGE
Target $23
MAXM
Hold
Pure Storage price target raised to $23 at Maxim after 'solid results'
Maxim analyst Nehal Chokshi raised his price target on Pure Storage to $23 from $21 after the company's Q1 earnings, saying that despite the deceleration in its growth trajectory, the results suggest that it is still on track to "sustaining 30% annual growth". The analyst keeps his Hold rating on the shares, adding that the stock appears to be "fairly valued".
NTAP NetApp
$79.39

0.61 (0.77%)

06/20/18
WELS
06/20/18
NO CHANGE
Target $80
WELS
Market Perform
NetApp price target raised to $80 from $65 at Wells Fargo
Wells Fargo analyst Aaron Rakers raised his price target for NetApp to $80 from $65 following positive meetings with the company's CEO and increasing confidence in $5-plus/share. The analyst reiterates a Market Perform rating on the shares.
06/25/18
UBSW
06/25/18
NO CHANGE
Target $80
UBSW
Buy
NetApp share price supported by earnings and free cash flow, says UBS
UBS analyst Steven Milunovich met with NetApp management and came away confident in its product portfolio, ability to take market share, and the belief that cloud revenue estimates could be conservative. The analyst believes the current guidance could be low in the near-term and he expects future earnings beats and strong free cash flow to support a higher stock price. Milunovich reiterated his Buy rating and $80 price target on NetApp shares.
07/05/18
ARGS
07/05/18
NO CHANGE
Target $90
ARGS
Buy
NetApp price target raised to $90 from $76 at Argus
Argus analyst Jim Kelleher raised his price target on NetApp (NTAP) to $90 and kept his Buy rating, citing the company's new offerings along with its partner Cisco (CSCO) in their FlexPod data management solutions business. The analyst notes that the first of these solutions designed to simplify IT infrastructure and data management for healthcare customers and organizations has already been launched, with more verticals expected to be addressed by additional solutions later this year. While "vanishing into Cisco's vast P&L", Kelleher tells investors that FlexPod is a material part of NetApp's business, adding that its market share may grow as rival Dell EMC is focused to bring a part of the company public.
06/26/18
PIPR
06/26/18
NO CHANGE
Target $86
PIPR
Overweight
NetApp price target raised to $86 from $77 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target on NetApp to $86 from $77 after hosting a call with Jeff Baxter, Senior Director of Technical Marketing and Chief Evangelist of ONTAP. In a research note to investors, Nowinski, who reiterated an Overweight rating, said the call focused on NVMe primarily, and that management said NetApp was the first vendor to ship an end-to-end enterprise NVMe system, and that other vendors with multiple platforms will likely have trouble implementing front-end and back-end NVMe across all their platforms. Additionally, management said NetApp will remain focused on storage development and rely on hardware suppliers to develop better-performing NVMe flash storage media. Finally, NetApp averaged two SAN displacements per day in FY18, though those wins were not driven by NVMe, since it had not yet started shipping, Nowinski notes, adding that he believes NVMe will accelerate the SAN displacement opportunity going forward.
CSCO Cisco
$42.69

-0.03 (-0.07%)

06/28/18
FBCO
06/28/18
NO CHANGE
Target $303
FBCO
Outperform
Arista continues to take share in data center switching, says Credit Suisse
Credit Suisse analyst Sami Badri notes Arista Networks (ANET) continues to take over the data center switching market. According to I.H.S. Markit, Arista grew its revenue market share in Q1 to 14.8%, taking share away from Cisco (CSCO) and Huawei. The analyst recommends Arista for its strong market position, as it grew its market share 210bps, and highlights its strength in the DC market as the company was able to maintain its product revenues on an absolute basis, despite Q1 being a seasonally weak quarter across the industry. Badri reiterates an Outperform rating and $303 price target on Arista shares.
07/09/18
PIPR
07/09/18
NO CHANGE
Target $50
PIPR
Overweight
Piper checks imply Cisco losing security share to Palo Alto
Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's have seen in past calendar quarters for Cisco Systems (CSCO). Cisco in previous quarters had positive 40% net-scores in Networking compared to a negative 2% this quarter, suggesting a more in-line quarter, Fish tells investors in a research note. Further, Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst adds. Fish "slightly reduced" his estimates for Cisco but says the stock remains his top networking pick. He keeps an Overweight rating on the name with a $50 price target.
07/09/18
07/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GAMESTOP STARTED WITH A BUY: Jefferies analyst Stephanie Wissink started GameStop (GME) with a Buy rating and $18 price target. Her contrarian view on the stock is that under potential new leadership with a well defined vision and execution plan, the stock's valuation, which she feels is "overlooked and overly discounted," could improve. GameStop is higher by 2.5% in midday trading. PIPER SEES CISCO LOSING SECURITY SHARE TO PALO ALTO: Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's seen in past calendar quarters for Cisco Systems (CSCO). Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst said, although the former remains his top networking pick. He kept an Overweight rating on Cisco shares, which were down almost 1% in midday trading. JEFFERIES DOWNGRADES P&G: Jefferies analyst Kevin Grundy downgraded Procter & Gamble (PG) to Hold from Buy and lowered his price target for the shares to $79 from $83. Slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower, Grundy told investors in a research note titled "Tide Unlikely to Turn: Downgrade to Hold as Bull Thesis Wanes." Grundy said he preferred shares of Church & Dwight (CHD) and Energizer (ENR) for exposure to the Home and Personal Care space. TRADE DESK STARTED WITH A SELL: Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating. WELLS FARGO DOWNGRADES TWO THEME PARKS: Wells Fargo analyst Timothy Conder downgraded both SeaWorld (SEAS) and Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns, and weather impact, despite ongoing favorable consumer fundamentals and the key Q3 just starting. SeaWorld is trading down 1.3%, while Six Flags is down 1.7% at midday.
NTNX Nutanix
$53.13

-0.63 (-1.17%)

06/25/18
WBLR
06/25/18
NO CHANGE
WBLR
Outperform
Nutanix recently signed its largest single deal, says William Blair
William Blair analyst Jason Ader said in a note to investors before the market open that his checks indicated that a Nutanix channel partner won a $45M deal with the U.S. Air Forces Central Command. While the $45M figure is to the end-user and will not all flow to Nutanix, Ader still believes this is the largest single deal in Nutanix's history, he told investors. The analyst, who sees the company having "tremendous momentum" in the federal vertical, keeps an Outperform rating on Nutanix shares, which are down $3.30, or 6%, to $51.04 in early trading.
07/02/18
WBLR
07/02/18
NO CHANGE
WBLR
Outperform
William Blair has increased conviction in Nutanix after management meetings
William Blair analyst Jason Ader left investor meetings last week with Nutanix CFO Duston Williams and Chief Product Officer Sunil Potti with increased conviction in the story and the company's path to $3B in billings in fiscal 2021. The analyst believes investors may be overlooking that Nutanix's financial model is 100% time-based and not perpetual, and that the vast majority of its product has shipped since fiscal year 2016, which he says sets up a "powerful renewal cycle" starting in fiscal 2020. Ader keeps an Outperform rating on Nutanix.
06/13/18
RBCM
06/13/18
NO CHANGE
Target $70
RBCM
Outperform
Nutanix price target raised to $70 from $62 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on Nutanix to $70 and kept his Outperform rating after his meetings with its management, saying the company is successfully navigating the transition to subscription revenue. The analyst also maintains his bullish view on the company's ability to "disrupt large areas of legacy" spending, including storage, compute, virtualization, security, and networking through an "easy-to-use and highly automated hybrid-cloud platform".
05/25/18
JEFF
05/25/18
NO CHANGE
Target $60
JEFF
Buy
Nutanix continues to execute on transition, says Jefferies
Jefferies analyst John DiFucci says Nutanix reported another solid quarter of business momentum with billings growing 50% year-over-year. While higher than expected operating expenses partially mitigated the outlook, the company continues to execute its transition to a pure software business where it will decrease its pass-through hardware sales, DiFucci tells investors in a post-earnings research note. He believes the transition will benefit the business and eventually margins as well. The analyst keeps a Buy rating on Nutanix with a $60 price target.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$319.85

-10.4 (-3.15%)

14:57
10/20/18
10/20
14:57
10/20/18
14:57
Conference/Events
Biogen to host conference call »

Chief Medical Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

14:13
10/20/18
10/20
14:13
10/20/18
14:13
Conference/Events
Selecta Biosciences to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TROV

Trovagene

$1.12

-0.03 (-2.61%)

14:11
10/20/18
10/20
14:11
10/20/18
14:11
Conference/Events
Trovagene to host conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLS

Sellas Life Sciences

$1.56

-0.24 (-13.33%)

13:54
10/20/18
10/20
13:54
10/20/18
13:54
Conference/Events
Sellas Life Sciences to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 07

    Nov

NVS

Novartis

$87.19

0.95 (1.10%)

13:50
10/20/18
10/20
13:50
10/20/18
13:50
Conference/Events
Novartis to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

UA

Under Armour

$16.79

-0.365 (-2.13%)

, UAA

Under Armour

$18.20

-0.42 (-2.26%)

12:43
10/20/18
10/20
12:43
10/20/18
12:43
Periodicals
Under Armour stock could triple, Barron's says »

Under Armour has had a…

UA

Under Armour

$16.79

-0.365 (-2.13%)

UAA

Under Armour

$18.20

-0.42 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 30

    Oct

  • 27

    Nov

  • 03

    Mar

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

, CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

12:37
10/20/18
10/20
12:37
10/20/18
12:37
Periodicals
Constellation Brands changing CEOs, not marijuana strategy, Barron's says »

Constellation Brands…

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 14

    Nov

CFG

Citizens Financial

$36.36

1.44 (4.12%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:33
10/20/18
10/20
12:33
10/20/18
12:33
Periodicals
Citizens Financial stock worth buying, Barron's says »

Citizens Financial (CFG)…

CFG

Citizens Financial

$36.36

1.44 (4.12%)

AAPL

Apple

$219.28

3.3 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.95

-1 (-0.65%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:26
10/20/18
10/20
12:26
10/20/18
12:26
Periodicals
Netflix emerged as winner in new way to rank big tech stocks risk, Barron's says »

A year ago,…

FB

Facebook

$153.95

-1 (-0.65%)

AAPL

Apple

$219.28

3.3 (1.53%)

AMZN

Amazon.com

$1,763.91

-7.54 (-0.43%)

NFLX

Netflix

$332.69

-14.02 (-4.04%)

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

DIS

Disney

$118.81

2.55 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 03

    Mar

BABA

Alibaba

$142.90

1.1 (0.78%)

, TCEHY

Tencent

$0.00

(0.00%)

12:17
10/20/18
10/20
12:17
10/20/18
12:17
Periodicals
Chinese internet giants down, not out, Barron's says »

Alibaba (BABA), Tencent…

BABA

Alibaba

$142.90

1.1 (0.78%)

TCEHY

Tencent

$0.00

(0.00%)

BIDU

Baidu

$191.93

0.1 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 02

    Nov

BLK

BlackRock

$401.61

1.74 (0.44%)

, IVZ

Invesco

$22.00

0.74 (3.48%)

12:13
10/20/18
10/20
12:13
10/20/18
12:13
Periodicals
Fund companies sued by own employees over pricey 401k plans, Barron's says »

BlackRock (BLK),…

BLK

BlackRock

$401.61

1.74 (0.44%)

IVZ

Invesco

$22.00

0.74 (3.48%)

TROW

T. Rowe Price

$100.13

0.31 (0.31%)

SCHW

Charles Schwab

$46.81

0.11 (0.24%)

MTB

M&T Bank

$162.72

2.09 (1.30%)

MS

Morgan Stanley

$46.43

0.4 (0.87%)

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 26

    Feb

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

, BLK

BlackRock

$401.61

1.74 (0.44%)

12:04
10/20/18
10/20
12:04
10/20/18
12:04
Periodicals
Khashoggi case puts financial ties to Saudis under strain, Barron's says »

The suspected killing of…

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

BLK

BlackRock

$401.61

1.74 (0.44%)

BX

Blackstone

$34.66

-0.61 (-1.73%)

AMC

AMC Entertainment

$19.81

0.18 (0.92%)

IMAX

Imax

$22.45

-0.11 (-0.49%)

SIX

Six Flags

$66.40

-1.16 (-1.72%)

WWE

WWE

$82.02

-1.49 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 14

    Nov

  • 26

    Feb

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

A

Agilent

$64.47

-1.28 (-1.95%)

, AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
American Society of Human Genetics to hold a conference »

ASHG Conference 2018 will…

A

Agilent

$64.47

-1.28 (-1.95%)

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

BMRN

BioMarin

$103.31

-0.52 (-0.50%)

BIO

Bio-Rad

$280.96

-3.23 (-1.14%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

ILMN

Illumina

$313.31

-7.98 (-2.48%)

FLDM

Fluidigm

$7.49

-0.45 (-5.67%)

HZNP

Horizon Pharma

$19.07

-0.01 (-0.05%)

NVTA

Invitae

$12.86

-0.23 (-1.76%)

NSTG

NanoString

$15.18

-0.41 (-2.63%)

QGEN

Qiagen

$35.91

0.455 (1.28%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

RTRX

Retrophin

$25.34

0.24 (0.96%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ARQL

ArQule

$4.33

-0.38 (-8.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 27

    Nov

  • 28

    Nov

  • 24

    Dec

  • 18

    Feb

  • 03

    Mar

CLBR

Caliburn International

$0.00

(0.00%)

18:27
10/19/18
10/19
18:27
10/19/18
18:27
Syndicate
Caliburn International files registration statement for proposed IPO »

Caliburn International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

18:10
10/19/18
10/19
18:10
10/19/18
18:10
General news
Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$99.62

2.61 (2.69%)

18:02
10/19/18
10/19
18:02
10/19/18
18:02
Hot Stocks
Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe »

Celanese announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

REGN

Regeneron

$389.94

-5.45 (-1.38%)

, SNY

Sanofi

$44.57

0.12 (0.27%)

17:57
10/19/18
10/19
17:57
10/19/18
17:57
Hot Stocks
Regeneron, Sanofi: FDA approves asthma indication for Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$389.94

-5.45 (-1.38%)

SNY

Sanofi

$44.57

0.12 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

, XLU

Utilities SPDR

$54.57

0.82 (1.53%)

17:55
10/19/18
10/19
17:55
10/19/18
17:55
General news
Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound »

S&P500 SECTORS: …

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

IYR

DJ US Real Estate Index Fund

$77.83

0.63 (0.82%)

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

XLF

Financial Select Sector

$26.66

0.08 (0.30%)

XLV

Health Care Select Sector SPDR

$91.48

-0.93 (-1.01%)

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

XLI

Industrial Select Sector SPDR

$73.17

-0.31 (-0.42%)

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

SLV

iShares Silver Trust

$13.74

0.05 (0.37%)

USO

United States Oil Fund

$14.72

0.155 (1.06%)

UNG

United States Natural Gas Fund

$26.81

0.19 (0.71%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.90

0.04 (0.05%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.69

-0.15 (-0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$113.73

-0.24 (-0.21%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.12

-0.12 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$82.95

-0.035 (-0.04%)

IWD

iShares Russell 1000 Value

$122.17

0.08 (0.07%)

IWF

iShares Russell 1000 Growth

$145.19

-0.5 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSW

International Seaways

$21.51

0.41 (1.94%)

17:53
10/19/18
10/19
17:53
10/19/18
17:53
Syndicate
Breaking Syndicate news story on International Seaways »

International Seaways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$15.49

0.08 (0.52%)

17:48
10/19/18
10/19
17:48
10/19/18
17:48
Hot Stocks
Monmouth Real Estate acquires industrial building in New Jersey for $85.25M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:38
10/19/18
10/19
17:38
10/19/18
17:38
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

TEUM

Pareteum

$2.47

-0.07 (-2.76%)

17:36
10/19/18
10/19
17:36
10/19/18
17:36
Syndicate
Breaking Syndicate news story on Pareteum »

Pareteum files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

, LMT

Lockheed Martin

$328.22

0.21 (0.06%)

17:33
10/19/18
10/19
17:33
10/19/18
17:33
Periodicals
Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports »

President Donald Trump…

NOC

Northrop Grumman

$307.77

-0.445 (-0.14%)

LMT

Lockheed Martin

$328.22

0.21 (0.06%)

BA

Boeing

$356.28

-3 (-0.84%)

GD

General Dynamics

$190.43

-0.76 (-0.40%)

BAESY

BAE Systems

$0.00

(0.00%)

HON

Honeywell

$153.49

-1.73 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.